MADISON — Harnessing the power of stem cells in previously unexplored ways, Stemina Biomarker Discovery, Inc. is one of the newest startups to spring out of Madisonâ??s thriving biotechnology sector.
Elizabeth Donley, the companyâ??s chief executive officer, presented Steminaâ??s scientific goals and business model at the recent Molecular Medicine Tri-Conference in San Francisco.
Donley explained that when human embryonic stem cells are grown in culture, they can be used for disease diagnosis, screening drugs for side effects and reducing development costs of pharmaceuticals.